If gastroparesis is not treated, it could contribute to malnutrition, dehydration, the formation of a bezoar (a solid mass inside the stomach), and a host of other health problems
In recent months, Eli Lilly, the maker of Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy, have each said that they are able to meet the demand for the medications after facing shortages since 2022 due to the drugs' growing popularity
Beinaglutide showed significant weight-loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real-world setting: a 3-month, multicentre, observational, retrospective, open-label study
New Research on Health Impacts Emerging studies on PFAS continue to reveal troubling links between these chemicals and various health issues: Legal Actions, Accountability, and Awareness efforts